PSME3 and central nervous system cancer: However, double immunostaining with anti-PD-L1 and anti-KI-67 antibodies revealed that PD-L1 was expressed predominantly by KI-67− tumor stem-like cells (lacking the KI-67 marker) derived from gliomas and medulloblastomas [14].